Shanghai Pharmaceuticals Holding Co., Ltd SHPMY
$7.24
-$0.15-1.97%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 8.24% | 11.91% | 6.07% | 4.72% | 2.35% |
| Total Other Revenue | 33.42% | -- | -2.08% | -13.17% | 13.32% |
| Total Revenue | 8.41% | 11.91% | 5.94% | 4.67% | 2.42% |
| Cost of Revenue | 7.98% | 11.29% | 5.24% | 4.63% | 3.27% |
| Gross Profit | 11.99% | 17.35% | 11.52% | 4.99% | -4.07% |
| SG&A Expenses | 5.90% | 17.93% | 8.53% | 11.88% | 3.33% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 631.19% | -0.18% | 344.46% | 2,326.52% | -131.12% |
| Total Operating Expenses | 8.23% | 11.60% | 6.12% | 5.33% | 2.79% |
| Operating Income | 13.65% | 21.30% | 0.16% | -15.56% | -7.19% |
| Income Before Tax | -26.82% | 18.25% | 12.25% | -18.92% | 94.36% |
| Income Tax Expenses | -41.66% | 16.83% | 2.48% | 22.60% | 95.31% |
| Earnings from Continuing Operations | -21.01% | 18.69% | 18.35% | -30.46% | 93.99% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -88.18% | -48.12% | -19.45% | 3.33% | 31.02% |
| Net Income | -29.01% | 11.91% | 17.59% | -38.11% | 123.66% |
| EBIT | 13.65% | 21.30% | 0.16% | -15.56% | -7.19% |
| EBITDA | 12.09% | 21.62% | 3.36% | -13.10% | -2.53% |
| EPS Basic | -28.99% | 11.94% | 15.87% | -37.20% | 125.10% |
| Normalized Basic EPS | -46.52% | 4.34% | -31.62% | -15.24% | 164.99% |
| EPS Diluted | -28.74% | 11.94% | 13.23% | -37.20% | 126.95% |
| Normalized Diluted EPS | -46.52% | 4.34% | -31.62% | -15.24% | 164.99% |
| Average Basic Shares Outstanding | 0.00% | 0.01% | 1.82% | -1.58% | -0.70% |
| Average Diluted Shares Outstanding | 0.00% | 0.01% | 1.82% | -1.58% | -0.70% |
| Dividend Per Share | -11.45% | -- | 22.58% | -- | 50.91% |
| Payout Ratio | 0.05% | 0.56% | -0.24% | 0.13% | -0.31% |